Evaluation of galectin-3 and intestinal fatty acid binding protein as serum biomarkers in autosomal recessive polycystic kidney disease.
Lindsay T FleischerLance BallesterMohini DuttKathryn HowarthLaura PoznickKassa DargeSusan L FurthErum A HartungPublished in: Journal of nephrology (2022)
Serum Gal-3 is associated with eGFR in ARPKD, suggesting its value as a possible novel biomarker of kidney disease severity. We found no associations between serum I-FABP and ARPKD liver disease severity despite overall elevated I-FABP levels.